fbpx
Chelsea Meloche, MD
See Publications

Texas Heart Institute Positions

Education

  • Medical School:

    Michigan State University College of Human Medicine – Upper Peninsula (Marquette)

  • Residency:

    University of Michigan

Publications

Luo, S., Vasbinder, A., Du-Fay-de-Lavallaz, J. M. et al. (2022). Soluble urokinase plasminogen sctivator teceptor and venous thromboembolism in COVID-19. J Am Heart Assoc, e025198. https://doi.org/10.1161/JAHA.122.025198.
Keene, A. B., Admon, A. J., Brenner, S. K. et al. (2022). Association of surge conditions with mortality among critically ill patients with COVID-19. J Intensive Care Med 37, 500–509. https://doi.org/10.1177/08850666211067509.
Vasbinder, A., Anderson, E., Shadid, H. et al. (2022). Inflammation, hyperglycemia, and adverse outcomes in individuals with diabetes mellitus hospitalized for COVID-19. Diabetes Care 45, 692–700. https://doi.org/10.2337/dc21-2102.
Hsu, C. M., Gupta, S., Tighiouart, H. et al. (2022). Kidney recovery and death in critically ill patients with COVID-19-associated acute kidney injury treated with dialysis: The STOP-COVID Cohort Study. Am J Kidney Dis 79, 404-416.e1. https://doi.org/10.1053/j.ajkd.2021.11.004.
Azam, T. U., Berlin, H., Anderson, E. et al. (2022). Differences in Inflammation, Treatment, and Outcomes Between Black and Non-Black Patients Hospitalized for COVID-19: A Prospective Cohort Study. Am J Med 135, 360–368. https://doi.org/10.1016/j.amjmed.2021.10.026.
Ricardo, A. C., Chen, J., Toth-Manikowski, S. M. et al. (2022). Hispanic ethnicity and mortality among critically ill patients with COVID-19. PLoS One 17, e0268022. https://doi.org/10.1371/journal.pone.0268022.
Pan, M., Vasbinder, A., Anderson, E. et al. (2021). Angiotensin-Converting Enzyme Inhibitors, Angiotensin II Receptor Blockers, and Outcomes in Patients Hospitalized for COVID-19. J Am Heart Assoc 10, e023535. https://doi.org/10.1161/JAHA.121.023535.
Friedman, A. N., Guirguis, J., Kapoor, R. et al. (2021). Obesity, inflammatory and thrombotic markers, and major clinical outcomes in critically ill patients with COVID-19 in the US. Obesity (Silver Spring) 29, 1719–1730. https://doi.org/10.1002/oby.23245.
Jezmir, J. L., Bharadwaj, M., Chaitoff, A. et al. (2021). Performance of crisis standards of care guidelines in a cohort of critically ill COVID-19 patients in the United States. Cell Rep Med 2, 100376. https://doi.org/10.1016/j.xcrm.2021.100376.
Meloche, C., Seth, M., Madder, R. D. et al. (2021). Percutaneous Coronary Intervention in Patients With a History of Gastrointestinal Bleeding (From the Blue Cross Blue Shield of Michigan Cardiovascular Consortium). Am J Cardiol 155, 9–15. https://doi.org/10.1016/j.amjcard.2021.06.013.